The Innovative Health Initiative (IHI) is a European Partnership under Horizon Europe, funded jointly by the European Union via HE and by health industry partners.
The Innovative Health Initiative (IHI) is a large-scale public–private partnership that brings together the EU and health industry stakeholders to accelerate the development of innovative healthcare solutions. It funds collaborative, cross-sector projects that tackle complex challenges—spanning medicines, medical technologies, digital health, and patient care. By fostering collaboration between academia, industry, SMEs, and patient organisations, IHI aims to deliver more integrated, sustainable, and patient-centred innovations for Europe’s health systems.
Open Calls:
The Innovative Health Initiative (IHI) Draft topics for upcoming Innovative Health Initiative (IHI) calls are now available, with updates expected in early June. If you are planning to apply, registration for the IHI Call Days is now open — a key opportunity to learn more about the calls, funding priorities and application process. IHI is also offering training and masterclasses on its “Field Manual for Scaling Innovation” to help projects turn research results into real-world impact.
The IHI Call Days for IHI call 13 will take place from 24 to 30 June online and will include sessions on the individual topics as well as the rules and procedures. It will spotlight some of the most pressing challenges and opportunities in health innovation, from advancing immuno-science in age-related diseases to exploring the future of AI-driven toxicology models for safer drug development.
Sessions will also cover the launch of the European healthcare incubator network and provide practical guidance on the rules and procedures for two-stage calls, helping applicants navigate upcoming funding opportunities and collaborative research initiatives – Register here
